Top

Clinical Reviews in Allergy & Immunology

Published in:

01-12-2019 | Chronic Inflammatory Bowel Disease

Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases

Authors: Youssouf Sereme, Soraya Mezouar, Ghiles Grine, Jean Louis Mege, Michel Drancourt, Pierre Corbeau, Joana Vitte

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2019

Abstract

Archaea, which form one of four domains of life alongside Eukarya, Bacteria, and giant viruses, have long been neglected as components of the human microbiota and potential opportunistic infectious pathogens. In this review, we focus on methanogenic Archaea, which rely on hydrogen for their metabolism and growth. On one hand, methanogenic Archaea in the gut are functional associates of the fermentative digestion of dietary fibers, favoring the production of beneficial short-chain fatty acids and likely contributing to the weaning reaction during the neonatal window of opportunity. On the other hand, methanogenic Archaea trigger the activation of innate and adaptive responses and the generation of specific T and B cells in animals and humans. In mouse models, lung hypersensitivity reactions can be induced by inhaled methanogenic Archaea mimicking human professional exposure to organic dust. Changes in methanogenic Archaea of the microbiota are detected in an array of dysimmune conditions comprising inflammatory bowel disease, obesity, malnutrition, anorexia, colorectal cancer, and diverticulosis. At the subcellular level, methanogenic Archaea are activators of the TLR8-dependent NLRP3 inflammasome, modulate the release of antimicrobial peptides and drive the production of proinflammatory, Th-1, Th-2, and Th-17 cytokines. Our objective was to introduce the most recent and major pieces of evidence supporting the involvement of Archaea in the balance between health and dysimmune diseases, with a particular focus on atopic and allergic conditions.

Lagier J-C, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain J-M, Fournier P-E, Raoult D (2018) Culturing the human microbiota and culturomics. Nat Rev Microbiol 16:540–550. https://doi.org/10.1038/s41579-018-0041-0 CrossRefPubMed

MetaHIT Consortium, Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. https://doi.org/10.1038/nature08821 CrossRefPubMedCentral

Rajilić-Stojanović M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38:996–1047. https://doi.org/10.1111/1574-6976.12075 CrossRefPubMedPubMedCentral

Virgin HW (2014) The virome in mammalian physiology and disease. Cell 157:142–150. https://doi.org/10.1016/j.cell.2014.02.032 CrossRefPubMedPubMedCentral

Huffnagle GB, Noverr MC (2013) The emerging world of the fungal microbiome. Trends Microbiol 21:334–341. https://doi.org/10.1016/j.tim.2013.04.002 CrossRefPubMedPubMedCentral

Parfrey LW, Walters WA, Lauber CL, Clemente JC, Berg-Lyons D, Teiling C, Kodira C, Mohiuddin M, Brunelle J, Driscoll M, Fierer N, Gilbert JA, Knight R (2014) Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity. Front Microbiol 5:298. https://doi.org/10.3389/fmicb.2014.00298 CrossRefPubMedPubMedCentral

Brosschot TP, Reynolds LA (2018) The impact of a helminth-modified microbiome on host immunity. Mucosal Immunol 11:1039–1046. https://doi.org/10.1038/s41385-018-0008-5 CrossRefPubMed

Horz H-P (2015) Archaeal lineages within the human microbiome: absent, rare or elusive? Life Basel Switz 5:1333–1345. https://doi.org/10.3390/life5021333 CrossRef

Nkamga VD, Henrissat B, Drancourt M (2017) Archaea: essential inhabitants of the human digestive microbiota. Hum Microbiome J 3:1–8. https://doi.org/10.1016/j.humic.2017.11.005 CrossRef

10.

Dridi B, Henry M, El Khéchine A, Raoult D, Drancourt M (2009) High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 4:e7063. https://doi.org/10.1371/journal.pone.0007063 CrossRefPubMedPubMedCentral

11.

Dridi B, Raoult D, Drancourt M (2012) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of Archaea: towards the universal identification of living organisms. APMIS Acta Pathol Microbiol Immunol Scand 120:85–91. https://doi.org/10.1111/j.1600-0463.2011.02833.x CrossRef

12.

Borrel G, Harris HMB, Tottey W, Mihajlovski A, Parisot N, Peyretaillade E, Peyret P, Gribaldo S, O’Toole PW, Brugère J-F (2012) Genome sequence of “Candidatus Methanomethylophilus alvus” Mx1201, a methanogenic archaeon from the human gut belonging to a seventh order of methanogenic Archaea. J Bacteriol 194:6944–6945. https://doi.org/10.1128/JB.01867-12 CrossRefPubMedPubMedCentral

13.

Carbonero F, Benefiel AC, Gaskins HR (2012) Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol 9:504–518. https://doi.org/10.1038/nrgastro.2012.85 CrossRefPubMed

14.

Samuel BS, Hansen EE, Manchester JK, Coutinho PM, Henrissat B, Fulton R, Latreille P, Kim K, Wilson RK, Gordon JI (2007) Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci U S A 104:10643–10648. https://doi.org/10.1073/pnas.0704189104 CrossRefPubMedPubMedCentral

15.

Dridi B, Henry M, Richet H, Raoult D, Drancourt M (2012) Age-related prevalence of Methanomassiliicoccus luminyensis in the human gut microbiome. APMIS 120:773–777. https://doi.org/10.1111/j.1600-0463.2012.02899.x CrossRefPubMed

16.

Ferrari A, Brusa T, Rutili A, Canzi E, Biavati B (1994) Isolation and characterization of Methanobrevibacter oralis sp. nov. Curr Microbiol 29:7–12CrossRef

17.

Nguyen-Hieu T, Khelaifia S, Aboudharam G, Drancourt M (2013) Methanogenic archaea in subgingival sites: a review. APMIS Acta Pathol Microbiol Immunol Scand 121:467–477CrossRef

18.

Khelaifia S, Raoult D, Drancourt M (2013) A versatile medium for cultivating methanogenic archaea. PLoS One 8:e61563. https://doi.org/10.1371/journal.pone.0061563 CrossRefPubMedPubMedCentral

19.

Gaci N, Borrel G, Tottey W, O’Toole PW, Brugère JF (2014) Archaea and the human gut: new beginning of an old story. World J Gastroenterol 20:16062–16078CrossRef

20.

Demonfort Nkamga V, Armstrong N, Drancourt M (2017) In vitro susceptibility of cultured human methanogens to lovastatin. Int J Antimicrob Agents 49:176–182CrossRef

21.

Koskinen K, Pausan MR, Perras AK, Beck M, Bang C, Mora M, Schilhabel A, Schmitz R, Moissl-Eichinger C (2017) First insights into the diverse human archaeome: specific detection of archaea in the gastrointestinal tract, lung, and nose and on skin. MBio 8(6):Pii: e00824-17. https://doi.org/10.1128/mBio.00824-17 CrossRef

22.

Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci 108:4680–4687. https://doi.org/10.1073/pnas.1002611107 CrossRefPubMed

23.

Chaudhary PP, Conway PL, Schlundt J (2018) Methanogenic Archaea in humans: potentially beneficial or harmful for health. Appl Microbiol Biotechnol 102:3095–3104. https://doi.org/10.1007/s00253-018-8871-2 CrossRefPubMed

24.

Ishaq SL, Moses PL, Wright A-DG (2016) The pathology of methanogenic archaea in human gastrointestinal tract disease. In: Mozsik G (ed) The Gut Microbiome - Implications for Human Disease. InTech. https://doi.org/10.5772/61423

25.

Gribaldo S, Forterre P, Brochier-Armanet C (2011) Archaea and the tree of life. Res Microbiol 162:1–4. https://doi.org/10.1016/j.resmic.2010.11.007 CrossRefPubMed

26.

Garcia JL, Patel BK, Ollivier B (2000) Taxonomic, phylogenetic, and ecological diversity of methanogenic archaea. Anaerobe 6:205–226. https://doi.org/10.1006/anae.2000.0345 CrossRefPubMed

27.

Liu Y, Whitman WB (2008) Metabolic, phylogenetic, and ecological diversity of the methanogenic archaea. Ann N Y Acad Sci 1125:171–189. https://doi.org/10.1196/annals.1419.019 CrossRefPubMed

28.

Balch WE, Fox GE, Magrum LJ, Woese CR, Wolfe RS (1979) Methanogenic Archaea: reevaluation of a unique biological group. Microbiol Rev 43:260–296PubMedPubMedCentral

29.

Bang C, Schmitz RA (2018) Archaea: forgotten players in the microbiome. Emerg Top Life Sci 2:459–468. https://doi.org/10.1042/ETLS20180035 CrossRef

30.

Grine G, Boualam MA, Drancourt M (2017) Methanobrevibacter smithii, a MA consistently colonising the newborn stomach. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 36:2449–2455. https://doi.org/10.1007/s10096-017-3084-7 CrossRef

31.

Sagheddu V, Patrone V, Miragoli F, Morelli L (2017) Abundance and diversity of hydrogenotrophic microorganisms in the infant gut before the weaning period assessed by denaturing gradient gel electrophoresis and quantitative PCR. Front Nutr 4:29. https://doi.org/10.3389/fnut.2017.00029 CrossRefPubMedPubMedCentral

32.

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031. https://doi.org/10.1038/nature05414 CrossRefPubMed

33.

Weaver GA, Krause JA, Miller TL, Wolin MJ (1986) Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis. Gut 27:698–704CrossRef

34.

Yazici C, Arslan DC, Abraham R, Cushing K, Keshavarzian A, Mutlu EA (2016) Breath methane levels are increased among patients with diverticulosis. Dig Dis Sci 61:2648–2654. https://doi.org/10.1007/s10620-016-4174-6 CrossRefPubMedPubMedCentral

35.

Ghavami SB, Rostami E, Sephay AA, Shahrokh S, Balaii H, Aghdaei HA, Zali MR (2018) Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microb Pathog 117:285–289. https://doi.org/10.1016/j.micpath.2018.01.029 CrossRefPubMed

36.

Blais Lecours P, Marsolais D, Cormier Y, Berberi M, Haché C, Bourdages R, Duchaine C (2014) Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One 9:e87734. https://doi.org/10.1371/journal.pone.0087734 CrossRefPubMedPubMedCentral

37.

Samuel BS, Gordon JI (2006) A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 103:10011–10016. https://doi.org/10.1073/pnas.0602187103 CrossRefPubMedPubMedCentral

38.

Zhang H et al (2009) Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106:2365–2370CrossRef

39.

Armougom F, Henry M, Vialettes B, Raccah D, Raoult D (2009) Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogenic archaea in anorexic patients. PLoS One 4:e7125. https://doi.org/10.1371/journal.pone.0007125 CrossRefPubMedPubMedCentral

40.

Million M, Tidjani Alou M, Khelaifia S, Bachar D, Lagier J-C, Dione N, Brah S, Hugon P, Lombard V, Armougom F, Fromonot J, Robert C, Michelle C, Diallo A, Fabre A, Guieu R, Sokhna C, Henrissat B, Parola P, Raoult D (2016) Increased gut redox and depletion of anaerobic and methanogenic prokaryotes in severe acute malnutrition. Sci Rep 6:26051CrossRef

41.

Ramezani A, Nolin TD, Barrows IR, Serrano MG, Buck GA, Regunathan-Shenk R, West RE 3rd, Latham PS, Amdur R, Raj DS (2018) Gut colonization with methanogenic archaea lowers plasma trimethylamine N-oxide concentrations in apolipoprotein e−/− mice. Sci Rep 8:14752. https://doi.org/10.1038/s41598-018-33018-5 CrossRefPubMedPubMedCentral

42.

Brugère JF, Borrel G, Gaci N, Tottey W, O’Toole PW, Malpuech-Brugère C (2014) Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease. Gut Microbes 5:5–10. https://doi.org/10.4161/gmic.26749 CrossRefPubMed

43.

Bang C, Ehlers C, Orell A, Prasse D, Spinner M, Gorb SN, Albers S-V, Schmitz RA (2014) Biofilm formation of mucosa-associated methanoarchaeal strains. Front Microbiol 5:353. https://doi.org/10.3389/fmicb.2014.00353 CrossRefPubMedPubMedCentral

44.

Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA (2014) The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells. PLoS One 9:e99411. https://doi.org/10.1371/journal.pone.0099411 CrossRefPubMedPubMedCentral

45.

Vierbuchen T, Bang C, Rosigkeit H, Schmitz RA, Heine H (2017) The human-associated archaeon Methanosphaera stadtmanae is recognized through its RNA and induces TLR8-dependent NLRP3 inflammasome activation. Front Immunol 8:1535. https://doi.org/10.3389/fimmu.2017.01535 CrossRefPubMedPubMedCentral

46.

Vierbuchen T, Stein K, Heine H (2019) RNA is taking its toll: impact of RNA-specific toll-like receptors on health and disease. Allergy 74:223–235. https://doi.org/10.1111/all.13680 CrossRefPubMed

47.

Huynh HTT, Pignoly M, Drancourt M, Aboudharam G (2017) A new methanogenic archaeon “Methanobrevibacter massiliense” isolated in a case of severe periodontitis. BMC Res Notes 10:657. https://doi.org/10.1186/s13104-017-2980-3 CrossRefPubMedPubMedCentral

48.

Huynh HTT, Pignoly M, Nkamga VD, Drancourt M, Aboudharam G (2015) The repertoire of archaea cultivated from severe periodontitis. PLoS One 10:e0121565. https://doi.org/10.1371/journal.pone.0121565 CrossRefPubMedPubMedCentral

49.

Deng ZL, Szafrański SP, Jarek M, Bhuju S, Wagner-Döbler I (2017) Dysbiosis in chronic periodontitis: key microbial players and interactions with the human host. Sci Rep 7:3703. https://doi.org/10.1038/s41598-017-03804-8 CrossRefPubMedPubMedCentral

50.

Li CL, Liu DL, Jiang YT, Zhou YB, Zhang MZ, Jiang W, Liu B, Liang JP (2009) Prevalence and molecular diversity of Archaea in subgingival pockets of periodontitis patients. Oral Microbiol Immunol 24:343–346. https://doi.org/10.1111/j.1399-302X.2009.00514.x CrossRefPubMed

51.

Lira EA, Ramiro FS, Chiarelli FM, Dias RR, Feres M, Figueiredo LC, Faveri M (2013) Reduction in prevalence of Archaea after periodontal therapy in subjects with generalized aggressive periodontitis. Aust Dent J 58:442–447. https://doi.org/10.1111/adj.12123 CrossRefPubMed

52.

Ramiro FS, de Lira E, Soares G, Retamal-Valdes B, Feres M, Figueiredo LC, Faveri M (2018) Effects of different periodontal treatments in changing the prevalence and levels of Archaea present in the subgingival biofilm of subjects with periodontitis: a secondary analysis from a randomized controlled clinical trial. Int J Dent Hyg 16:569–575. https://doi.org/10.1111/idh.12347 CrossRefPubMed

53.

Lourenςo TGB, Spencer SJ, Alm EJ, Colombo APV (2018) Defining the gut microbiota in individuals with periodontal diseases: an exploratory study. J Oral Microbiol 10(1):1487741. https://doi.org/10.1080/20002297.2018.1487741 CrossRefPubMedPubMedCentral

54.

Grine G, Lotte R, Chirio D, Chevalier A, Raoult D, Drancourt M, Ruimy R (2019) Coculture of Methanobrevibacter smithii with enterobacteria during urinary infection. EBioMedicine 43:333–337. https://doi.org/10.1016/j.ebiom.2019.04.037 CrossRefPubMedPubMedCentral

55.

Sogodogo E, Fellag M, Loukil A, Nkamga VD, Michel J, Dessi P, Fournier PE, Drancourt M (2019) Nine cases of methanogenic archaea in refractory sinusitis, an emerging clinical entity. Front Public Health 7:38. https://doi.org/10.3389/fpubh.2019.00038 CrossRefPubMedPubMedCentral

56.

Nkamga VD, Lotte R, Roger PM, Drancourt M, Ruimy R (2016) Methanobrevibacter smithii and Bacteroides thetaiotaomicron cultivated from a chronic paravertebral muscle abscess. Clin Microbiol Infect 22:1008–1009. https://doi.org/10.1016/j.cmi.2016.09.007 CrossRefPubMed

57.

Drancourt M, Nkamga VD, Lakhe NA, Régis JM, Dufour H, Fournier PE, Bechah Y, Scheld WM, Raoult D (2017) Evidence of archaeal methanogens in brain abscess. Clin Infect Dis 65:1–5. https://doi.org/10.1093/cid/cix286 CrossRefPubMed

58.

Sogodogo E, Drancourt M, Grine G (2019) Methanogenic Archaea as emerging pathogens in anaerobic abscesses. Eur J Clin Microbiol Infect Dis 38:811–818. https://doi.org/10.1007/s10096-019-03510-5 CrossRefPubMed

59.

Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, Hugerth LW, Bindl L, Bottu J, Andersson AF, de Beaufort C, Wilmes P (2017) Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life. Front Microbiol 8:738. https://doi.org/10.3389/fmicb.2017.00738 CrossRefPubMedPubMedCentral

60.

Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Núñez G, Martens EC (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167:1339-1353.e21. https://doi.org/10.1016/j.cell.2016.10.043 CrossRefPubMedPubMedCentral

61.

Martens EC, Neumann M, Desai MS (2018) Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol 16:457–470. https://doi.org/10.1038/s41579-018-0036-x ReviewCrossRefPubMed

62.

Nkamga VD, Lotte R, Chirio D, Lonjon M, Roger PM, Drancourt M, Ruimy R (2018) Methanobrevibacter oralis detected along with Aggregatibacter actinomycetemcomitans in a series of community-acquired brain abscesses. Clin Microbiol Infect 24:207–208. https://doi.org/10.1016/j.cmi.2017.08.021 CrossRefPubMed

63.

Bond JH Jr, Engel RR, Levitt MD Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria (1971). J Exp Med 133:572–588

64.

Scanlan PD, Shanahan F, Marchesi JR (2008) Human MA diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol 8:79. https://doi.org/10.1186/1471-2180-8-79 CrossRefPubMedPubMedCentral

65.

Traore SI, Khelaifia S, Armstrong N, Lagier JC, Raoult D (2019) Isolation and culture of Methanobrevibacter smithii by co-culture with hydrogen-producing bacteria on agar plates. Clin Microbiol infect:Pii: S1198-743X(19)30160-0. https://doi.org/10.1016/j.cmi.2019.04.008

66.

Moissl-Eichinger C, Pausan M, Taffner J, Berg G, Bang C, Schmitz RA (2018) Archaea are interactive components of complex microbiomes. Trends Microbiol 26:70–85. https://doi.org/10.1016/j.tim.2017.07.004 CrossRefPubMed

67.

Bang C, Vierbuchen T, Gutsmann T, Heine H, Schmitz RA (2017) Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides. PLoS One 12:e0185919. https://doi.org/10.1371/journal.pone.0185919 CrossRefPubMedPubMedCentral

68.

Blais Lecours P, Duchaine C, Taillefer M, Tremblay C, Veillette M, Cormier Y, Marsolais D (2011) Immunogenic properties of archaeal species found in bioaerosols. PLoS One 6:e23326. https://doi.org/10.1371/journal.pone.0023326 CrossRefPubMedPubMedCentral

69.

Bernatchez E, Gold MJ, Langlois A, Blais-Lecours P, Boucher M, Duchaine C, Marsolais D, McNagny KM, Blanchet M-R (2017) Methanosphaera stadtmanae induces a type IV hypersensitivity response in a mouse model of airway inflammation. Physiol rep 5:e13163. Doi: https://doi.org/10.14814/phy2.13163 CrossRef

70.

Krishnan L, Sprott GD (2008) Archaeosome adjuvants: immunological capabilities and mechanism(s) of action. Vaccine 26:2043–2055. https://doi.org/10.1016/j.vaccine.2008.02.026 CrossRefPubMed

71.

Jacobsen AC, Jensen SM, Fricker G, Brandl M, Treusch AH (2017) Archaeal lipids in oral delivery of therapeutic peptides. Eur J Pharm Sci 108:101–110. https://doi.org/10.1016/j.ejps.2016.12.036 CrossRefPubMed

72.

Sprott GD, Tolson DL, Patel GB (1997) Archaeosomes as novel antigen delivery systems. FEMS Microbiol Lett 154:17–22CrossRef

73.

Jia Y, Akache B, Deschatelets L, Qian H, Dudani R, Harrison BA, Stark FC, Chandan V, Jamshidi MP, Krishnan L, McCluskie MJ (2019) A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations. Int J Pharm 561:187–196. https://doi.org/10.1016/j.ijpharm.2019.02.041 CrossRefPubMed

74.

Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force (2001) A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56:813–824 Review. Erratum in: Allergy 2001 Dec;56(12):1229

75.

Huang YJ, Marsland BJ, Bunyavanich S, O’Mahony L, Leung DY, Muraro A, Fleisher TA (2017) The microbiome in allergic disease: current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol 139:1099–1110. https://doi.org/10.1016/j.jaci.2017.02.007 CrossRefPubMedPubMedCentral

76.

Mezouar S, Chantran Y, Michel J, Fabre A, Dubus JC, Leone M, Mège JL, Ranque S, Desnues B, Chanez P, Vitte J (2018) Microbiome and the immune system: from a healthy steady-state to allergy associated disruption and asthma. Human Microbiome J 10:11–20. https://doi.org/10.1016/j.humic.2018.10.001 CrossRef

77.

Barnett DJM, Mommers M, Penders J, Arts ICW, Thijs C (2019) Intestinal archaea inversely associated with childhood asthma. J Allergy Clin Immunol 143:2305–2307. https://doi.org/10.1016/j.jaci.2019.02.009 CrossRefPubMed

78.

van de Pol JA, van Best N, Mbakwa CA, Thijs C, Savelkoul PH, Arts IC, Hornef MW, Mommers M, Penders J (2017) Gut colonization by methanogenic archaea is associated with organic dairy consumption in children. Front Microbiol 8:355. https://doi.org/10.3389/fmicb.2017.00355 CrossRefPubMedPubMedCentral

79.

Brantsæter AL, Ydersbond TA, Hoppin JA, Haugen M, Meltzer HM (2017) Organic food in the diet: exposure and health implications. Annu Rev Public Health 38:295–313. https://doi.org/10.1146/annurev-publhealth-031816-044437 CrossRefPubMed

80.

Kummeling I, Thijs C, Huber M, van de Vijver LP, Snijders BE, Penders J, Stelma F, van Ree R, van den Brandt PA, Dagnelie PC (2008) Consumption of organic foods and risk of atopic disease during the first 2 years of life in the Netherlands. Br J Nutr 99:598–605CrossRef

81.

Quirce S, Vandenplas O, Campo P, Cruz MJ, de Blay F, Koschel D, Moscato G, Pala G, Raulf M, Sastre J, Siracusa A, Tarlo SM, Walusiak-Skorupa J, Cormier Y (2016) Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy 71:765–779. https://doi.org/10.1111/all.12866 CrossRefPubMed

82.

Just N, Blais Lecours P, Marcoux-Voiselle M, Kirychuk S, Veillette M, Singh B, Duchaine C (2013) Archaeal characterization of bioaerosols from cage-housed and floor-housed poultry operations. Can J Microbiol 59:46–50. https://doi.org/10.1139/cjm-2012-0305 CrossRefPubMed

83.

Boucher M, Blais Lecours P, Létourneau V, Veillette M, Duchaine C, Marsolais D (2018) Organic components of airborne dust influence the magnitude and kinetics of dendritic cell activation. Toxicol in Vitro 50:391–398. https://doi.org/10.1016/j.tiv.2018.04.011 CrossRefPubMed

84.

Veillette M, Knibbs LD, Pelletier A, Charlebois R, Blais Lecours P, He C, Morawska L, Duchaine C (2013) Microbial contents of vacuum cleaner bag dust and emitted bioaerosols and their implications for human exposure indoors. Appl Environ Microbiol 79:6331–6336. https://doi.org/10.1128/AEM.01583-13 CrossRefPubMedPubMedCentral

85.

Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159–166. https://doi.org/10.1038/nm.3444 CrossRefPubMed

86.

Al Nabhani Z, Dulauroy S, Marques R, Cousu C, Al Bounny S, Déjardin F, Sparwasser T, Bérard M, Cerf-Bensussan N, Eberl G (2019) A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity 50:1276-1288.e5. https://doi.org/10.1016/j.immuni.2019.02.014 CrossRefPubMed

87.

Torow N, Hornef MW (2017) The neonatal window of opportunity: setting the stage for life-long host-microbial interaction and immune homeostasis. J Immunol 198:557–563. https://doi.org/10.4049/jimmunol.1601253 CrossRefPubMed

88.

Renz H, Adkins BD, Bartfeld S, Blumberg RS, Farber DL, Garssen J, Ghazal P, Hackam DJ, Marsland BJ, McCoy KD, Penders J, Prinz I, Verhasselt V, von Mutius E, Weiser JN, Wesemann DR, Hornef MW (2018) The neonatal window of opportunity-early priming for life. J Allergy Clin Immunol 141:1212–1214. https://doi.org/10.1016/j.jaci.2017.11.019 CrossRefPubMed

Title: Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases
Authors: Youssouf Sereme
Soraya Mezouar
Ghiles Grine
Jean Louis Mege
Michel Drancourt
Pierre Corbeau
Joana Vitte
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Chronic Inflammatory Bowel Disease
Respiratory Microbiota
Published in: Clinical Reviews in Allergy & Immunology / Issue 3/2019
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-019-08766-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

The Clinical Utility of Pollen Counts

The Role of the Environment in Eosinophilic Esophagitis

The Human Microbiota and Asthma

The Impact of Environmental Chronic and Toxic Stress on Asthma

Possible Role of Environmental Factors in the Development of Food Allergies

The Myth of Mycotoxins and Mold Injury

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page